The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
United Therapeutics and DEKA announced receipt of 510(k) clearance by the FDA for the Unity Subcutaneous Delivery System for Remodulin Injection.
read more
RegeneRx announced the first patient has been enrolled in ARISE-3, a phase 3 clinical trial sponsored by ReGenTree, a U.S. joint venture between ...
read more
NanoViricides has completed manufacture of the drug for the upcoming GLP Safety/Toxicology study of its lead candidate in several kilogram quantities.
read more
The FDA approved Fragmin injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism in pediatric patients one ...
read more
UCB announced the FDA has approved NAYZILAM® nasal spray CIV, a benzodiazepine indicated for the acute treatment of intermittent, stereotypic episodes...
read more
Stryker announced the Premarket Approval (PMA) of the Neuroform Atlas Stent System by the FDA.
read more
Intec Pharma has announced the European Patent Office has granted the Company European Patent No. 2997953 titled, "DELIVERY DEVICE FOR ORAL INTAKE OF ...
read more
Eli Lilly and Company's Insulin Lispro Injection is now available for order in pharmacies for people who use Lilly's rapid-acting insulin and need a ...
read more
Armas Pharmaceuticals and Micro Labs USA have announced the forming of a strategic collaboration to bring select multisource injectable products to ...
read more
Windtree Therapeutics and Eleison announced positive results of the feasibility study using Windtree's proprietary Aerosol Delivery System ...
read more
The FDA approved Emgality (galcanezumab-gnlm) solution for injection for the treatment of episodic cluster headache in adults.
read more
GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline announced the FDA has approved two new methods for administering Nucala, an autoinjector and a pre-filled safety syringe.
read more
Alnylam announced new advances in its RNAi therapeutics platform, including preclinical results demonstrating oral delivery of GalNAc-conjugated small...
read more
The FDA is warning patients and health care providers that certain Medtronic MiniMed insulin pumps are being recalled due to potential cybersecurity ...
read more
Grifols has announced Xembify®, its new 20% subcutaneous immunoglobulin, has been approved by the FDA.
read more